Product owner profile
HYPHEN BioMed
Singapore·6 devices ownedProfile overview
- Total Devices
- 6
- Device Classes
- 2
- Earliest
- 2020
- Latest
- 2024
Recent registrations
Latest 10 HSA device registrations
HYPHEN BIOPHEN DiXalNov 15, 2024
Registration: DE0510047
Class: CLASS C IVD
HYPHEN Revohem Arachidonic acidJul 01, 2020
Registration: DE0504660
Class: CLASS C IVD
HYPHEN Revohem ADPJun 19, 2020
Registration: DE0504614
Class: CLASS C IVD
HYPHEN Revohem EpinephrineJun 05, 2020
Registration: DE0504562
Class: CLASS B IVD
HYPHEN Revohem RistocetinJun 05, 2020
Registration: DE0504563
Class: CLASS B IVD
HYPHEN Revohem CollagenJun 05, 2020
Registration: DE0504564
Class: CLASS B IVD
Device class distribution
Devices by class
- CLASS B IVD
- 3 (50.0%)
- CLASS C IVD
- 3 (50.0%)
About this profile
Explore comprehensive product owner profile for HYPHEN BioMed through Pure Global AI's free Singapore medical device database. This company owns 6 medical devices registered with HSA across 2 device classes. Their registration history spans from Jun 05, 2020 to Nov 15, 2024.
This page provides detailed insights including recent registrations, device class distribution (CLASS B IVD: 3, CLASS C IVD: 3), and complete regulatory information from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry.
Free Owner ProfilePowered by Pure Global AI6 Devices2 Device Classes